HAHaemonetics HAE · NYSE
$118.76 +0.41% (+$0.48)
- Market cap
- $5.40B
- Enterprise value
- $6.35B
- P/E
- 56.1x
- Forward P/E
- 21.4x
- PEG
- 0.8x
- P/S
- 4.0x
- P/FCF
- 18.6x
- EV/EBITDA
- 24.3x
- ROIC
- 8.6%
- Bruto marža
- 57.4%
- Neto marža
- 7.1%
- Dividend yield
- -
- Payout ratio
- -
- Neto dolg/EBITDA
- 3.6x
- Beta
- 0.54
- Free float
- 98.7%
O podjetju
Haemonetics Corporation is an American company specializing in the development and manufacturing of medical technologies focused on blood product processing. Founded in 1971, the company’s primary focus is on innovations in blood transfusion, blood component separation, and patient monitoring. Haemonetics provides products and solutions for hospitals, blood banks, and transfusion centers that help optimize the processes of blood donation and usage, while ensuring safety and treatment efficiency. The company is known for its advanced devices and systems for separating plasma, red blood cells, and platelets, ensuring precision and quality in handling blood products.
Sector
Healthcare
Industry
Medical - Devices
CEO
Christopher A. Simon
Employees
3,009
Headquarters
Boston
Vrednotenje
Je današnja cena primerna?
Rast in ocene
Ali podjetje raste in kaj sledi?
Donosnost in kakovost
Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?
Finančno zdravje
Ali zmore svoj dolg?
Kapital in dividende
Kaj podjetje počne z zasluženim denarjem?
Analitiki
Kaj menijo strokovnjaki in ali se to spreminja?
Lastniki in insajderji
Kdo ima delnice in kaj počne vodstvo?
Segmenti
Kateri del podjetja raste?
Primerjava s konkurenco
Kako se primerja s podobnimi podjetji?
Cena in tveganje
Kako se delnica obnaša?
Izkazi
Vse številke